nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—Aphthous stomatitis—Epirubicin—bone cancer	0.0243	0.0243	CcSEcCtD
Midodrine—Pain—Carboplatin—bone cancer	0.0231	0.0231	CcSEcCtD
Midodrine—Aphthous stomatitis—Doxorubicin—bone cancer	0.0225	0.0225	CcSEcCtD
Midodrine—Irritability—Cisplatin—bone cancer	0.0154	0.0154	CcSEcCtD
Midodrine—Scotoma—Epirubicin—bone cancer	0.015	0.015	CcSEcCtD
Midodrine—Hyperaesthesia—Epirubicin—bone cancer	0.0145	0.0145	CcSEcCtD
Midodrine—Scotoma—Doxorubicin—bone cancer	0.0139	0.0139	CcSEcCtD
Midodrine—Hyperaesthesia—Doxorubicin—bone cancer	0.0134	0.0134	CcSEcCtD
Midodrine—Abdominal discomfort—Cisplatin—bone cancer	0.0133	0.0133	CcSEcCtD
Midodrine—Vasodilation—Epirubicin—bone cancer	0.013	0.013	CcSEcCtD
Midodrine—Vasodilation procedure—Epirubicin—bone cancer	0.013	0.013	CcSEcCtD
Midodrine—Hepatic enzyme increased—Methotrexate—bone cancer	0.0129	0.0129	CcSEcCtD
Midodrine—Stomatitis—Cisplatin—bone cancer	0.0121	0.0121	CcSEcCtD
Midodrine—Vasodilation—Doxorubicin—bone cancer	0.012	0.012	CcSEcCtD
Midodrine—Vasodilation procedure—Doxorubicin—bone cancer	0.012	0.012	CcSEcCtD
Midodrine—Hepatobiliary disease—Cisplatin—bone cancer	0.0117	0.0117	CcSEcCtD
Midodrine—Bradycardia—Cisplatin—bone cancer	0.0113	0.0113	CcSEcCtD
Midodrine—Urinary tract disorder—Cisplatin—bone cancer	0.011	0.011	CcSEcCtD
Midodrine—Urethral disorder—Cisplatin—bone cancer	0.0109	0.0109	CcSEcCtD
Midodrine—Cramps of lower extremities—Epirubicin—bone cancer	0.0105	0.0105	CcSEcCtD
Midodrine—Flushing—Cisplatin—bone cancer	0.0103	0.0103	CcSEcCtD
Midodrine—Cardiac disorder—Cisplatin—bone cancer	0.0103	0.0103	CcSEcCtD
Midodrine—Cramps of lower extremities—Doxorubicin—bone cancer	0.00968	0.00968	CcSEcCtD
Midodrine—Flatulence—Cisplatin—bone cancer	0.00955	0.00955	CcSEcCtD
Midodrine—Hepatic function abnormal—Epirubicin—bone cancer	0.00945	0.00945	CcSEcCtD
Midodrine—Muscle spasms—Cisplatin—bone cancer	0.00932	0.00932	CcSEcCtD
Midodrine—Hepatic function abnormal—Doxorubicin—bone cancer	0.00875	0.00875	CcSEcCtD
Midodrine—Irritability—Methotrexate—bone cancer	0.00843	0.00843	CcSEcCtD
Midodrine—Anxiety—Cisplatin—bone cancer	0.00822	0.00822	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00819	0.00819	CcSEcCtD
Midodrine—Nervous system disorder—Cisplatin—bone cancer	0.00775	0.00775	CcSEcCtD
Midodrine—Tachycardia—Cisplatin—bone cancer	0.00772	0.00772	CcSEcCtD
Midodrine—Skin disorder—Cisplatin—bone cancer	0.00768	0.00768	CcSEcCtD
Midodrine—Dry skin—Epirubicin—bone cancer	0.00757	0.00757	CcSEcCtD
Midodrine—Abdominal discomfort—Methotrexate—bone cancer	0.00732	0.00732	CcSEcCtD
Midodrine—Dysuria—Methotrexate—bone cancer	0.00714	0.00714	CcSEcCtD
Midodrine—Paraesthesia—Cisplatin—bone cancer	0.0071	0.0071	CcSEcCtD
Midodrine—Dyspnoea—Cisplatin—bone cancer	0.00705	0.00705	CcSEcCtD
Midodrine—Dry skin—Doxorubicin—bone cancer	0.00701	0.00701	CcSEcCtD
Midodrine—Gastrointestinal disorder—Cisplatin—bone cancer	0.00683	0.00683	CcSEcCtD
Midodrine—Pain—Cisplatin—bone cancer	0.00676	0.00676	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00675	0.00675	CcSEcCtD
Midodrine—Dysuria—Epirubicin—bone cancer	0.00668	0.00668	CcSEcCtD
Midodrine—Stomatitis—Methotrexate—bone cancer	0.00663	0.00663	CcSEcCtD
Midodrine—Pollakiuria—Epirubicin—bone cancer	0.0066	0.0066	CcSEcCtD
Midodrine—Feeling abnormal—Cisplatin—bone cancer	0.00652	0.00652	CcSEcCtD
Midodrine—Hepatobiliary disease—Methotrexate—bone cancer	0.00643	0.00643	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00631	0.00631	CcSEcCtD
Midodrine—Stomatitis—Epirubicin—bone cancer	0.00621	0.00621	CcSEcCtD
Midodrine—Dysuria—Doxorubicin—bone cancer	0.00618	0.00618	CcSEcCtD
Midodrine—Pollakiuria—Doxorubicin—bone cancer	0.0061	0.0061	CcSEcCtD
Midodrine—Urinary tract disorder—Methotrexate—bone cancer	0.00603	0.00603	CcSEcCtD
Midodrine—Hepatobiliary disease—Epirubicin—bone cancer	0.00602	0.00602	CcSEcCtD
Midodrine—Urethral disorder—Methotrexate—bone cancer	0.00599	0.00599	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00584	0.00584	CcSEcCtD
Midodrine—Bradycardia—Epirubicin—bone cancer	0.00582	0.00582	CcSEcCtD
Midodrine—Erythema multiforme—Methotrexate—bone cancer	0.00578	0.00578	CcSEcCtD
Midodrine—Stomatitis—Doxorubicin—bone cancer	0.00574	0.00574	CcSEcCtD
Midodrine—Asthenia—Cisplatin—bone cancer	0.00567	0.00567	CcSEcCtD
Midodrine—Cardiac disorder—Methotrexate—bone cancer	0.00567	0.00567	CcSEcCtD
Midodrine—Urinary tract disorder—Epirubicin—bone cancer	0.00564	0.00564	CcSEcCtD
Midodrine—Urethral disorder—Epirubicin—bone cancer	0.0056	0.0056	CcSEcCtD
Midodrine—Hepatobiliary disease—Doxorubicin—bone cancer	0.00557	0.00557	CcSEcCtD
Midodrine—Angiopathy—Methotrexate—bone cancer	0.00554	0.00554	CcSEcCtD
Midodrine—Chills—Methotrexate—bone cancer	0.00548	0.00548	CcSEcCtD
Midodrine—Erythema multiforme—Epirubicin—bone cancer	0.0054	0.0054	CcSEcCtD
Midodrine—Bradycardia—Doxorubicin—bone cancer	0.00538	0.00538	CcSEcCtD
Midodrine—Mental disorder—Methotrexate—bone cancer	0.00535	0.00535	CcSEcCtD
Midodrine—Cardiac disorder—Epirubicin—bone cancer	0.0053	0.0053	CcSEcCtD
Midodrine—Flushing—Epirubicin—bone cancer	0.0053	0.0053	CcSEcCtD
Midodrine—Urinary tract disorder—Doxorubicin—bone cancer	0.00522	0.00522	CcSEcCtD
Midodrine—Angiopathy—Epirubicin—bone cancer	0.00519	0.00519	CcSEcCtD
Midodrine—Urethral disorder—Doxorubicin—bone cancer	0.00518	0.00518	CcSEcCtD
Midodrine—Back pain—Methotrexate—bone cancer	0.00514	0.00514	CcSEcCtD
Midodrine—Chills—Epirubicin—bone cancer	0.00513	0.00513	CcSEcCtD
Midodrine—Mental disorder—Epirubicin—bone cancer	0.00501	0.00501	CcSEcCtD
Midodrine—Erythema multiforme—Doxorubicin—bone cancer	0.005	0.005	CcSEcCtD
Midodrine—Rash—Cisplatin—bone cancer	0.00499	0.00499	CcSEcCtD
Midodrine—Dermatitis—Cisplatin—bone cancer	0.00498	0.00498	CcSEcCtD
Midodrine—Cardiac disorder—Doxorubicin—bone cancer	0.00491	0.00491	CcSEcCtD
Midodrine—Flushing—Doxorubicin—bone cancer	0.00491	0.00491	CcSEcCtD
Midodrine—Flatulence—Epirubicin—bone cancer	0.0049	0.0049	CcSEcCtD
Midodrine—Tension—Epirubicin—bone cancer	0.00488	0.00488	CcSEcCtD
Midodrine—Nervousness—Epirubicin—bone cancer	0.00483	0.00483	CcSEcCtD
Midodrine—Back pain—Epirubicin—bone cancer	0.00481	0.00481	CcSEcCtD
Midodrine—Angiopathy—Doxorubicin—bone cancer	0.0048	0.0048	CcSEcCtD
Midodrine—Muscle spasms—Epirubicin—bone cancer	0.00478	0.00478	CcSEcCtD
Midodrine—Chills—Doxorubicin—bone cancer	0.00475	0.00475	CcSEcCtD
Midodrine—Nausea—Cisplatin—bone cancer	0.0047	0.0047	CcSEcCtD
Midodrine—Mental disorder—Doxorubicin—bone cancer	0.00463	0.00463	CcSEcCtD
Midodrine—Agitation—Epirubicin—bone cancer	0.00457	0.00457	CcSEcCtD
Midodrine—Flatulence—Doxorubicin—bone cancer	0.00454	0.00454	CcSEcCtD
Midodrine—Tension—Doxorubicin—bone cancer	0.00452	0.00452	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.0045	0.0045	CcSEcCtD
Midodrine—Nervousness—Doxorubicin—bone cancer	0.00447	0.00447	CcSEcCtD
Midodrine—Back pain—Doxorubicin—bone cancer	0.00445	0.00445	CcSEcCtD
Midodrine—Muscle spasms—Doxorubicin—bone cancer	0.00443	0.00443	CcSEcCtD
Midodrine—Confusional state—Methotrexate—bone cancer	0.00438	0.00438	CcSEcCtD
Midodrine—Hypertension—Epirubicin—bone cancer	0.0043	0.0043	CcSEcCtD
Midodrine—Nervous system disorder—Methotrexate—bone cancer	0.00426	0.00426	CcSEcCtD
Midodrine—Agitation—Doxorubicin—bone cancer	0.00423	0.00423	CcSEcCtD
Midodrine—Anxiety—Epirubicin—bone cancer	0.00422	0.00422	CcSEcCtD
Midodrine—Skin disorder—Methotrexate—bone cancer	0.00421	0.00421	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00421	0.00421	CcSEcCtD
Midodrine—Dry mouth—Epirubicin—bone cancer	0.00414	0.00414	CcSEcCtD
Midodrine—Confusional state—Epirubicin—bone cancer	0.00409	0.00409	CcSEcCtD
Midodrine—Nervous system disorder—Epirubicin—bone cancer	0.00398	0.00398	CcSEcCtD
Midodrine—Hypertension—Doxorubicin—bone cancer	0.00397	0.00397	CcSEcCtD
Midodrine—Tachycardia—Epirubicin—bone cancer	0.00396	0.00396	CcSEcCtD
Midodrine—Skin disorder—Epirubicin—bone cancer	0.00394	0.00394	CcSEcCtD
Midodrine—Insomnia—Methotrexate—bone cancer	0.00392	0.00392	CcSEcCtD
Midodrine—Anxiety—Doxorubicin—bone cancer	0.00391	0.00391	CcSEcCtD
Midodrine—Paraesthesia—Methotrexate—bone cancer	0.0039	0.0039	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00389	0.00389	CcSEcCtD
Midodrine—Dyspnoea—Methotrexate—bone cancer	0.00387	0.00387	CcSEcCtD
Midodrine—Somnolence—Methotrexate—bone cancer	0.00386	0.00386	CcSEcCtD
Midodrine—Dry mouth—Doxorubicin—bone cancer	0.00383	0.00383	CcSEcCtD
Midodrine—Dyspepsia—Methotrexate—bone cancer	0.00382	0.00382	CcSEcCtD
Midodrine—Confusional state—Doxorubicin—bone cancer	0.00379	0.00379	CcSEcCtD
Midodrine—Gastrointestinal disorder—Methotrexate—bone cancer	0.00375	0.00375	CcSEcCtD
Midodrine—Pain—Methotrexate—bone cancer	0.00371	0.00371	CcSEcCtD
Midodrine—Nervous system disorder—Doxorubicin—bone cancer	0.00368	0.00368	CcSEcCtD
Midodrine—Insomnia—Epirubicin—bone cancer	0.00367	0.00367	CcSEcCtD
Midodrine—Tachycardia—Doxorubicin—bone cancer	0.00367	0.00367	CcSEcCtD
Midodrine—Skin disorder—Doxorubicin—bone cancer	0.00365	0.00365	CcSEcCtD
Midodrine—Paraesthesia—Epirubicin—bone cancer	0.00365	0.00365	CcSEcCtD
Midodrine—Dyspnoea—Epirubicin—bone cancer	0.00362	0.00362	CcSEcCtD
Midodrine—Somnolence—Epirubicin—bone cancer	0.00361	0.00361	CcSEcCtD
Midodrine—Feeling abnormal—Methotrexate—bone cancer	0.00358	0.00358	CcSEcCtD
Midodrine—Dyspepsia—Epirubicin—bone cancer	0.00357	0.00357	CcSEcCtD
Midodrine—Gastrointestinal pain—Methotrexate—bone cancer	0.00355	0.00355	CcSEcCtD
Midodrine—Gastrointestinal disorder—Epirubicin—bone cancer	0.00351	0.00351	CcSEcCtD
Midodrine—Pain—Epirubicin—bone cancer	0.00347	0.00347	CcSEcCtD
Midodrine—Abdominal pain—Methotrexate—bone cancer	0.00343	0.00343	CcSEcCtD
Midodrine—Insomnia—Doxorubicin—bone cancer	0.0034	0.0034	CcSEcCtD
Midodrine—Paraesthesia—Doxorubicin—bone cancer	0.00337	0.00337	CcSEcCtD
Midodrine—Dyspnoea—Doxorubicin—bone cancer	0.00335	0.00335	CcSEcCtD
Midodrine—Feeling abnormal—Epirubicin—bone cancer	0.00335	0.00335	CcSEcCtD
Midodrine—Somnolence—Doxorubicin—bone cancer	0.00334	0.00334	CcSEcCtD
Midodrine—Gastrointestinal pain—Epirubicin—bone cancer	0.00332	0.00332	CcSEcCtD
Midodrine—Dyspepsia—Doxorubicin—bone cancer	0.00331	0.00331	CcSEcCtD
Midodrine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00324	0.00324	CcSEcCtD
Midodrine—Pain—Doxorubicin—bone cancer	0.00321	0.00321	CcSEcCtD
Midodrine—Abdominal pain—Epirubicin—bone cancer	0.00321	0.00321	CcSEcCtD
Midodrine—Asthenia—Methotrexate—bone cancer	0.00311	0.00311	CcSEcCtD
Midodrine—Feeling abnormal—Doxorubicin—bone cancer	0.0031	0.0031	CcSEcCtD
Midodrine—Gastrointestinal pain—Doxorubicin—bone cancer	0.00307	0.00307	CcSEcCtD
Midodrine—Pruritus—Methotrexate—bone cancer	0.00307	0.00307	CcSEcCtD
Midodrine—Abdominal pain—Doxorubicin—bone cancer	0.00297	0.00297	CcSEcCtD
Midodrine—Asthenia—Epirubicin—bone cancer	0.00291	0.00291	CcSEcCtD
Midodrine—Pruritus—Epirubicin—bone cancer	0.00287	0.00287	CcSEcCtD
Midodrine—Dizziness—Methotrexate—bone cancer	0.00287	0.00287	CcSEcCtD
Midodrine—Rash—Methotrexate—bone cancer	0.00274	0.00274	CcSEcCtD
Midodrine—Dermatitis—Methotrexate—bone cancer	0.00273	0.00273	CcSEcCtD
Midodrine—Headache—Methotrexate—bone cancer	0.00272	0.00272	CcSEcCtD
Midodrine—Asthenia—Doxorubicin—bone cancer	0.0027	0.0027	CcSEcCtD
Midodrine—Dizziness—Epirubicin—bone cancer	0.00269	0.00269	CcSEcCtD
Midodrine—Pruritus—Doxorubicin—bone cancer	0.00266	0.00266	CcSEcCtD
Midodrine—Nausea—Methotrexate—bone cancer	0.00258	0.00258	CcSEcCtD
Midodrine—Rash—Epirubicin—bone cancer	0.00256	0.00256	CcSEcCtD
Midodrine—Dermatitis—Epirubicin—bone cancer	0.00256	0.00256	CcSEcCtD
Midodrine—Headache—Epirubicin—bone cancer	0.00254	0.00254	CcSEcCtD
Midodrine—Dizziness—Doxorubicin—bone cancer	0.00248	0.00248	CcSEcCtD
Midodrine—Nausea—Epirubicin—bone cancer	0.00241	0.00241	CcSEcCtD
Midodrine—Rash—Doxorubicin—bone cancer	0.00237	0.00237	CcSEcCtD
Midodrine—Dermatitis—Doxorubicin—bone cancer	0.00237	0.00237	CcSEcCtD
Midodrine—Headache—Doxorubicin—bone cancer	0.00235	0.00235	CcSEcCtD
Midodrine—Nausea—Doxorubicin—bone cancer	0.00223	0.00223	CcSEcCtD
